Drug recall · May 16, 2018
Ampicillin and Sulbactam for Injection recall
Why: Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.
- Lots / codes
Lot #: AS0317041-A, AS0317035-A; Exp August 2019
- Quantity
- 54,720 vials
- Company
- AuroMedics Pharma LLC, East Windsor, NJ
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- May 1, 2018 · Voluntary: Firm initiated
- Classified
- June 14, 2018
- Reported
- May 16, 2018
- Ended
- November 6, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ampicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.